EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dual Disruption of EGFR/PI3K Signaling: IGF2BP2 Targeting Reverses Anti-EGFR Resistance in CAFs-Infiltrated Oral Squamous Cell Carcinoma

Yaying Hu, Tianshuang Zhu, Sheng Nong, Yanan Sun, Yiwei Li, Junchen Pan, Jiyuan Ma, Jiali Zhang iD

International Journal of Molecular Sciences · 22.04.2025 · 26 (9) · 3941

DOI: 10.3390/ijms26093941 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 22.04.2025. Verfasst von Yaying Hu und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Lab…. Hauptthemen laut MEDLINE: RNA-Binding Proteins, Drug Resistance, Neoplasm, Signal Transduction, Mouth Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RNA-binding proteins (RBPs) critically regulate post-transcriptional gene networks, yet their roles and mechanisms in oral squamous cell carcinoma (OSCC) remain underexplored. Dysregulated RBPs were identified through integrated analysis of RNA-seq and single-cell RNA-seq. The oncogenic functions of IGF2BP2 were evaluated through tissue microarrays, CCK-8, transwell assays, mouse xenografts, and Igf2bp2-deficient mouse models of tongue SCC (TSCC). Subsequently, we utilized RNA-seq, RIP-seq, RIP/MeRIP-qPCR, and dual-luciferase reporter assays to investigate IGF2BP2-target genes. Furthermore, cell co-culture system and mouse TSCC models were used to validate the therapeutic effect of the IGF2BP2 inhibitor. IGF2BP2 was the most markedly upregulated RBP in OSCC cells and cancer-associated fibroblasts (CAFs), correlating with unfavorable prognosis. IGF2BP2 deprivation significantly impaired human OSCC proliferation and metastasis, and delayed mouse TSCC onset. Mechanistically, IGF2BP2 stabilized EGFR and PIK3R1 mRNA via m6A-dependent interactions, thereby sustaining activation of the EGFR/PI3K/AKT oncogenic axis. Pharmacological inhibition of IGF2BP2 exhibited anti-OSCC efficacy in vivo and in vitro by concurrently suppressing EGFR and PI3K/AKT pathway activity, overcoming anti-EGFR resistance resulting from cell-intrinsic PI3K/AKT hyperactivation and CAF-secreted factors. Our findings identified IGF2BP2 as a master regulator of OSCC progression and a promising therapeutic target, offering an alternative strategy for OSCC patients suffering anti-EGFR resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA-Binding ProteinsDrug Resistance, NeoplasmSignal TransductionMouth NeoplasmsCarcinoma, Squamous CellPhosphatidylinositol 3-KinasesSquamous Cell Carcinoma of Head and NeckHumansAnimalsErbB ReceptorsMiceCell Line, TumorCell ProliferationGene Expression Regulation, NeoplasticXenograft Model Antitumor Assays

Stichwörter der Autor:innen

EGFR/PI3K/AKTIGF2BP2Igf2bp2-deficient micePIK3R1RBPscancer-associated fibroblastscetuximabm6A

Substanzen

ErbB ReceptorsRNA-Binding ProteinsIGF2BP2 protein, humanEGFR protein, humanPhosphatidylinositol 3-Kinases

Autor:innen und Institutionen

  • State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan Univer…
  • Department of Oral Pathology, School and Hospital of Stomatology, Wuhan University, Wuhan 430079, China.

ORCID-Profile: Jiali Zhang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Hu, Y., Zhu, T., Nong, S., Sun, Y., Li, Y., Pan, J., Ma, J., & Zhang, J. (2025). Dual Disruption of EGFR/PI3K Signaling: IGF2BP2 Targeting Reverses Anti-EGFR Resistance in CAFs-Infiltrated Oral Squamous Cell Carcinoma. International Journal of Molecular Sciences, 26(9), 3941. https://doi.org/10.3390/ijms26093941

Vancouver

Hu Y, Zhu T, Nong S, Sun Y, Li Y, Pan J, et al. Dual Disruption of EGFR/PI3K Signaling: IGF2BP2 Targeting Reverses Anti-EGFR Resistance in CAFs-Infiltrated Oral Squamous Cell Carcinoma. International Journal of Molecular Sciences. 2025;26(9):3941. doi:10.3390/ijms26093941

BibTeX
@article{Hu2025,
  author = {Hu, Yaying and Zhu, Tianshuang and Nong, Sheng and Sun, Yanan and Li, Yiwei and Pan, Junchen and Ma, Jiyuan and Zhang, Jiali},
  title = {Dual Disruption of EGFR/PI3K Signaling: IGF2BP2 Targeting Reverses Anti-EGFR Resistance in CAFs-Infiltrated Oral Squamous Cell Carcinoma},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {9},
  pages = {3941},
  doi = {10.3390/ijms26093941}
}
Kostenlos starten →